Singapore markets closed
Straits Times Index
3,415.51 +47.61 (+1.41%) S&P 500
5,507.42 -1.59 (-0.03%) Dow
39,376.06 +44.21 (+0.11%) Nasdaq
18,028.76 +149.46 (+0.84%) Bitcoin USD
60,269.54 -2,638.46 (-4.19%) CMC Crypto 200
1,292.84 -42.07 (-3.15%)
HOOKIPA Pharma Inc. (HOOK)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 0.6283 |
| Open | 0.6270 |
| Bid | 0.3990 x 200 |
| Ask | 0.7538 x 200 |
| Day's range | 0.5759 - 0.6300 |
| 52-week range | 0.4100 - 1.1300 |
| Volume | |
| Avg. volume | 875,161 |
| Market cap | 57.549M |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations
HOOKIPA Pharma ( NASDAQ:HOOK ) First Quarter 2024 Results Key Financial Results Revenue: US$36.6m (up by US$33.4m from...
- Benzinga
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Wednesday, HOOKIPA Pharma Inc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application for HB-700, a novel arenaviral therapeutic vaccine for the treatment of KRAS-mutated cancers. In January, Roche terminated the collaboration and licensing agreement for HOOKIPA’s HB-700 program in KRAS mutated cancers. HOOKIPA’s HB-700 program is designed to treat KRAS-mutated lung, colorectal, pancreatic, and other cancers by targeting the five most prevalent KRAS mutat
- Simply Wall St.
Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook
Today is shaping up negative for HOOKIPA Pharma Inc. ( NASDAQ:HOOK ) shareholders, with the analysts delivering a...
© 2024 Yahoo. All rights reserved.